The Discounted Cash Flow (DCF) valuation of Dawnrays Pharmaceutical (Holdings) Ltd (2348.HK) is 5.78 HKD. With the latest stock price at 1.26 HKD, the upside of Dawnrays Pharmaceutical (Holdings) Ltd based on DCF is 358.6%.
Based on the latest price of 1.26 HKD and our DCF valuation, Dawnrays Pharmaceutical (Holdings) Ltd (2348.HK) is a buy. buying 2348.HK stocks now will result in a potential gain of 358.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 10.0% | 8.0% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 4.66 - 7.97 | 5.78 |
| Upside | 269.5% - 532.3% | 358.6% |